Biotechnology
Compare Stocks
2 / 10Stock Comparison
MTSR vs PEPG
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
MTSR vs PEPG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Biotechnology |
| Market Cap | $7.43B | $123M |
| Revenue (TTM) | $0.00 | $0.00 |
| Net Income (TTM) | $-314M | $-90M |
| Total Debt | $10M | $17M |
| Cash & Equiv. | $352M | $61M |
Quick Verdict: MTSR vs PEPG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MTSR has the current edge in this matchup, primarily because of its strength in long-term compounding.
- 166.0% 10Y total return vs PEPG's -86.1%
- +204.7% vs PEPG's +42.1%
- -55.4% ROA vs PEPG's -60.4%
PEPG is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.17
- EPS growth 25.6%
- Lower volatility, beta 0.17, Low D/E 11.5%, current ratio 11.94x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Quality / Margins | 2.3% margin vs MTSR's 1.3% | |
| Stability / Safety | Beta 0.17 vs MTSR's 0.69 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +204.7% vs PEPG's +42.1% | |
| Efficiency (ROA) | -55.4% ROA vs PEPG's -60.4% |
MTSR vs PEPG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PEPG leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
MTSR and PEPG operate at a comparable scale, with $0 and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $0 |
| EBITDAEarnings before interest/tax | -$337M | -$90M |
| Net IncomeAfter-tax profit | -$314M | -$90M |
| Free Cash FlowCash after capex | -$232M | -$82M |
| Gross MarginGross profit ÷ Revenue | — | — |
| Operating MarginEBIT ÷ Revenue | — | — |
| Net MarginNet income ÷ Revenue | — | — |
| FCF MarginFCF ÷ Revenue | — | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +49.5% | +60.3% |
Valuation Metrics
Evenly matched — MTSR and PEPG each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $7.4B | $123M |
| Enterprise ValueMkt cap + debt − cash | $7.1B | $80M |
| Trailing P/EPrice ÷ TTM EPS | -34.73x | -0.84x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | — |
| Price / BookPrice ÷ Book value/share | 25.28x | 0.51x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
MTSR leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
PEPG delivers a -75.7% return on equity — every $100 of shareholder capital generates $-76 in annual profit, vs $-93 for MTSR. MTSR carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to PEPG's 0.12x. On the Piotroski fundamental quality scale (0–9), PEPG scores 4/9 vs MTSR's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -93.2% | -75.7% |
| ROA (TTM)Return on assets | -55.4% | -60.4% |
| ROICReturn on invested capital | — | -73.2% |
| ROCEReturn on capital employed | -84.5% | -63.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.03x | 0.12x |
| Net DebtTotal debt minus cash | -$343M | -$44M |
| Cash & Equiv.Liquid assets | $352M | $61M |
| Total DebtShort + long-term debt | $10M | $17M |
| Interest CoverageEBIT ÷ Interest expense | -2591.91x | — |
Total Returns (Dividends Reinvested)
MTSR leads this category, winning 5 of 5 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MTSR five years ago would be worth $26,604 today (with dividends reinvested), compared to $1,389 for PEPG. Over the past 12 months, MTSR leads with a +204.7% total return vs PEPG's +42.1%. The 3-year compound annual growth rate (CAGR) favors MTSR at 38.6% vs PEPG's -50.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | — | -75.0% |
| 1-Year ReturnPast 12 months | +204.7% | +42.1% |
| 3-Year ReturnCumulative with dividends | +166.0% | -88.1% |
| 5-Year ReturnCumulative with dividends | +166.0% | -86.1% |
| 10-Year ReturnCumulative with dividends | +166.0% | -86.1% |
| CAGR (3Y)Annualised 3-year return | +38.6% | -50.7% |
Risk & Volatility
Evenly matched — MTSR and PEPG each lead in 1 of 2 comparable metrics.
Risk & Volatility
PEPG is the less volatile stock with a 0.17 beta — it tends to amplify market swings less than MTSR's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MTSR currently trades 84.1% from its 52-week high vs PEPG's 22.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.35x | -0.10x |
| 52-Week HighHighest price in past year | $83.86 | $7.80 |
| 52-Week LowLowest price in past year | $21.10 | $1.01 |
| % of 52W HighCurrent price vs 52-week peak | +84.1% | +22.9% |
| RSI (14)Momentum oscillator 0–100 | 62.1 | 37.6 |
| Avg Volume (50D)Average daily shares traded | 0 | 1.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MTSR as "Buy" and PEPG as "Buy". Consensus price targets imply 291.1% upside for PEPG (target: $7) vs -21.3% for MTSR (target: $56).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $55.50 | $7.00 |
| # AnalystsCovering analysts | 4 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
MTSR leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). PEPG leads in 1 (Income & Cash Flow). 2 tied.
MTSR vs PEPG: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MTSR or PEPG a better buy right now?
Analysts rate Metsera, Inc.
(MTSR) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MTSR or PEPG?
Over the past 5 years, Metsera, Inc.
(MTSR) delivered a total return of +166. 0%, compared to -86. 1% for PepGen Inc. (PEPG). Over 10 years, the gap is even starker: MTSR returned +166. 0% versus PEPG's -86. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MTSR or PEPG?
By beta (market sensitivity over 5 years), PepGen Inc.
(PEPG) is the lower-risk stock at -0. 10β versus Metsera, Inc. 's 0. 35β — meaning MTSR is approximately -460% more volatile than PEPG relative to the S&P 500. On balance sheet safety, Metsera, Inc. (MTSR) carries a lower debt/equity ratio of 3% versus 12% for PepGen Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — MTSR or PEPG?
On earnings-per-share growth, the picture is similar: PepGen Inc.
grew EPS 25. 6% year-over-year, compared to -113. 7% for Metsera, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MTSR or PEPG?
Metsera, Inc.
(MTSR) is the more profitable company, earning 0. 0% net margin versus 0. 0% for PepGen Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MTSR leads at 0. 0% versus 0. 0% for PEPG. At the gross margin level — before operating expenses — MTSR leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MTSR or PEPG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MTSR or PEPG better for a retirement portfolio?
For long-horizon retirement investors, PepGen Inc.
(PEPG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 10)). Both have compounded well over 10 years (PEPG: -86. 3%, MTSR: +166. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MTSR and PEPG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.